Norveška -
norveščina -
Statens legemiddelverk
atarax 10 mg
ucb nordic as - hydroksyzinhydroklorid - tablett, filmdrasjert - 10 mg
Norveška -
norveščina -
Statens legemiddelverk
atarax 25 mg
ucb nordic as - hydroksyzinhydroklorid - tablett, filmdrasjert - 25 mg
Norveška -
norveščina -
Statens legemiddelverk
ketorax 5 mg
pfizer as - ketobemidonhydroklorid - tablett - 5 mg
Norveška -
norveščina -
Statens legemiddelverk
ketorax 5 mg/ ml
pfizer as - ketobemidonhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml
Evropska unija -
norveščina -
EMA (European Medicines Agency)
nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera og immunglobuliner, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
Norveška -
norveščina -
Statens legemiddelverk
ciprofloxacin actavis 500 mg
actavis group ptc ehf - ciprofloksacinhydroklorid - tablett, filmdrasjert - 500 mg
Norveška -
norveščina -
Statens legemiddelverk
ciprofloxacin actavis 250 mg
actavis group ptc ehf - ciprofloksacinhydroklorid - tablett, filmdrasjert - 250 mg
Norveška -
norveščina -
Statens legemiddelverk
ciprofloxacin aristo 250 mg
aristo pharma gmbh - ciprofloksacinhydroklorid - tablett, filmdrasjert - 250 mg
Norveška -
norveščina -
Statens legemiddelverk
ciprofloxacin aristo 500 mg
aristo pharma gmbh - ciprofloksacinhydroklorid - tablett, filmdrasjert - 500 mg
Norveška -
norveščina -
Statens legemiddelverk
ciprofloxacin aristo 750 mg
aristo pharma gmbh - ciprofloksacinhydroklorid - tablett, filmdrasjert - 750 mg